Intravenous Thrombolysis for Acute Ischemic Stroke with Prior Stroke and Diabetes: Think Different?

In Europe, health authorities have restricted the use of intravenous tissue plasminogen activator (IV TPA) in patients with both diabetes mellitus (DM)